98%
921
2 minutes
20
Portal cholangiopathy is one of the complications of the chronic portal vein thrombosis (PVT). Chronic PVT can occur in a patient with acute PVT that usually does not resolve regardless of the treatment. There is a development of collateral blood vessels that bring blood from the portal system towards the liver around the obstruction area, known as the cavernous transformation of the portal vein or portal cavernoma, in a patient with chronic PVT. The appearance and location of collateral channels depends on the extent and location of thrombus in the portomesenteric venous system. If the portomesenteric venous system is occluded near the formation of the portal vein, blood tends to flow through collateral channels that form varices in and around the common bile duct. Portal cholangiopathy (also referred to as portal biliopathy) is common in patients with long-standing chronic PVT. It is due to compression of the large bile ducts by the venous collaterals that form in patients with chronic PVT. Most of the patients with long-standing PVT have portal cholangiopathy. Typically, symptoms of portal cholangiopathy include jaundice, biliary colic, and pruritus. Portal cholangiopathy is a rare complication of chronic portal hypertension, and it is an important differential diagnosis of biliary colic secondary to cholelithiasis. The patient can also present with the sharp right upper quadrant pain, which is atypical by nature for biliary colic.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538209 | PMC |
http://dx.doi.org/10.7759/cureus.10281 | DOI Listing |
Korean J Gastroenterol
July 2025
Department of Child Health, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Background/aims: Biliary atresia (BA) is a progressive cholangiopathy of infancy that leads to cholestasis, bile duct fibrosis, and liver cirrhosis if untreated. This study aimed to evaluate the demographic, clinical, and laboratory characteristics of infants with BA and identify prognostic factors influencing treatment outcomes.
Methods: A retrospective observational design was used, analyzing medical records of 152 infants diagnosed with BA over a three-year period.
Pediatr Res
July 2025
Department of Paediatric Gastroenterology, Hepatology and Nutrition, King's College Hospital, London, UK.
Biliary atresia (BA) is a progressive cholangiopathy and the leading cause of pediatric liver transplantation. While its etiology remains unclear, factors such as developmental anomalies, viral infections, and immune dysregulation have been implicated. Early Kasai portoenterostomy (KPE) is the standard surgical intervention to restore bile flow, with serum bilirubin normalization serving as a key success indicator.
View Article and Find Full Text PDFCureus
June 2025
Transplant Surgery, Medical College of Wisconsin, Milwaukee, USA.
Celiac artery aneurysm is a rare entity among the visceral artery aneurysms, with a high risk of rupture, resulting in high mortality. Arterial complications, such as thrombosis, dissection, and hemorrhage, are among the most serious complications after liver transplantation (LT), which can lead to abscess formation, ischemic cholangiopathy, and hepatic ischemia and necrosis. Therefore, an adequate inflow of the hepatic artery is crucial to avoid any occlusion after LT.
View Article and Find Full Text PDFWorld J Pediatr Surg
June 2025
Department of Paediatric Surgery, King's College Hospital NHS Foundation Trust, London, England, UK.
Biliary atresia (BA) may be characterized as an obliterative cholangiopathy presenting in the newborn period with conjugated jaundice, pale stools, and dark urine. It is usually thought of as an isolated anomaly in otherwise normal infants. However, in a minority, other anomalies may be present, some as defined syndromes, others as a non-random association.
View Article and Find Full Text PDFSurg Case Rep
May 2025
Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
Introduction: Biliary atresia (BA) is a progressive cholangiopathy in neonates that results in biliary cirrhosis and liver failure without early intervention. Hepatic portoenterostomy (Kasai operation) remains the standard treatment, significantly improving survival rates. However, postoperative cholangitis is a major determinant of prognosis.
View Article and Find Full Text PDF